BICYCLE TUMOR-TARGETED IMMUNE CELL AGONIST Trademark

Trademark Overview


On Tuesday, October 27, 2020, a trademark application was filed for BICYCLE TUMOR-TARGETED IMMUNE CELL AGONIST with the United States Patent and Trademark Office. The USPTO has given the BICYCLE TUMOR-TARGETED IMMUNE CELL AGONIST trademark a serial number of 79301041. The federal status of this trademark filing is REGISTERED as of Tuesday, January 25, 2022. This trademark is owned by BicycleTX Limited. The BICYCLE TUMOR-TARGETED IMMUNE CELL AGONIST trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products, namely, pharmaceutical preparations for use in oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical preparations for use as diagnostics, namely, diagnostic preparations for medical use and for use as clinical imaging agents

Scientific and technological services and research and design relating thereto, namely, scientific research, new product design services, and new study design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; industrial analysis and research services in the fields of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic prepar...
bicycle tumor-targeted immune cell agonist

General Information


Serial Number79301041
Word MarkBICYCLE TUMOR-TARGETED IMMUNE CELL AGONIST
Filing DateTuesday, October 27, 2020
Status700 - REGISTERED
Status DateTuesday, January 25, 2022
Registration Number6624273
Registration DateTuesday, January 25, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements


Goods and ServicesPharmaceutical products, namely, pharmaceutical preparations for use in oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical preparations for use as diagnostics, namely, diagnostic preparations for medical use and for use as clinical imaging agents
NOT AVAILABLE"TUMOR-TARGETED IMMUNE CELL AGONIST"
Goods and ServicesScientific and technological services and research and design relating thereto, namely, scientific research, new product design services, and new study design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; industrial analysis and research services in the fields of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; information, consultancy and advisory services relating to the aforesaid

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, January 2, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBicycletx Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameBicycleTX Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameBicycleTX Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Saturday, January 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 31, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, January 6, 2021APPLICATION FILING RECEIPT MAILED
Friday, September 17, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, September 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, March 28, 2021ASSIGNED TO EXAMINER
Monday, March 29, 2021NON-FINAL ACTION WRITTEN
Tuesday, March 30, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, April 5, 2021REFUSAL PROCESSED BY MPU
Monday, April 5, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, April 25, 2021REFUSAL PROCESSED BY IB
Tuesday, September 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 21, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 25, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, July 2, 2022GENERIC MADRID TRANSACTION CREATED
Wednesday, March 26, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 26, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, March 26, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 26, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 26, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 26, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 1, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, April 25, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, July 2, 2022GENERIC MADRID TRANSACTION SENT TO IB
Monday, August 1, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, September 24, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB